There were 358 press releases posted in the last 24 hours and 401,477 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image